# A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

> **NCT00861068** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 44 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** SPM927/Lacosamide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00861068
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2002-12
- **Final completion:** 2003-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861068, "A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00861068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*